Trial · NCT01362348
Results by group77
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 77
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Central Retinal Lesion Thickness (CRT) as Measured by Optical Coherence Tomography (OCT) at Day 29 | Pazopanib 10 mg/mL QID | 37.91 | Standard Deviation 89.692 | Microns | |
| Change From Baseline in Best Correct Visual Acuity (BCVA) as Measured by the Number of Letters Determined by Electronic Early Treatment Diabetic Retinopathy [ETDRS] Study Visual Acuity (EVA) at Day 29 | Pazopanib 10 mg/mL QID | 0.07 | Standard Deviation 9.973 | Count of letters | |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Week 1 | -3.97 | Standard Deviation 93.420 | Microns |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Week 2 | -6.39 | Standard Deviation 93.420 | Microns |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Week 3 | 15.15 | Standard Deviation 86.646 | Microns |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Week 4 | 31.72 | Standard Deviation 88.289 | Microns |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Week 6 | 51.22 | Standard Deviation 84.679 | Microns |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Week 8 | 15.48 | Standard Deviation 82.304 | Microns |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Week 12 | -1.57 | Standard Deviation 75.216 | Microns |
| Change From Baseline in Central Retinal Lesion Thickness (CRLT) Over Time | Pazopanib 10 mg/mL QID | CRLT at Follow-up | -8.42 | Standard Deviation 91.346 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Week 1 | -34.79 | Standard Deviation 70.781 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Week 2 | -29.32 | Standard Deviation 71.654 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Week 3 | -0.22 | Standard Deviation 67.074 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Week 4 | 5.69 | Standard Deviation 67.938 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Week 6 | 28.05 | Standard Deviation 67.192 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Week 8 | 35.25 | Standard Deviation 64.689 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Week 12 | 1.72 | Standard Deviation 57.734 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | SR fluid thickness at Follow-up | 8.43 | Standard Deviation 70.329 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | PED thickness at Week 1 | 4.01 | Standard Deviation 56.669 | Microns |
| Change From Baseline in Intraretinal (IR) or Subretinal (SR) Fluid Thickness, Intraretinal Cysts or Serous Retinal Pigment Epithelial Detachment (PED Thickness) Over Time | Pazopanib 10 mg/mL QID | PED thickness at Week 2 | 4.47 | Standard Deviation 56.669 | Microns |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01362348/results